Gustave-Roussy and Sanofi are at the origin of a new research group which must bring together public and private, start-ups and large laboratories. To make ...
INTERVIEW – The CEO of Gustave-Roussy explains how the pandemic has changed the care of cancer patients. Oncologist and professor of medicine at Paris-Saclay University, ...
INVESTIGATION – Pasteur’s failure and Sanofi’s delays are just the tip of the iceberg. On many subjects, French research has missed the stakes. At the ...
GREAT DECRYPTION – Le Figaro looks back at the vaccine development process, from the first research on the antigen to the marketing authorization. “So this ...
Stéphane Bancel, the French CEO of the American biotech Moderna Therapeutics, who starteds Phase 3 clinical trials started in July, explained, at the microphone of ...